HistoRx is led by a team of outstanding pathology researchers and seasoned bioscience executives.

Our researchers from the Yale School of Medicine developed the novel molecular tissue pathology technology underlying the AQUA® platform.

Our Executive Team and Directors have led companies from startup to liquidity event. They have developed and commercialized technologies, negotiated alliances, launched products, driven sales, and served on corporate boards.